How to account for COVID-19 in a valuation?
How would you account for the effect of COVID-19 in each of the 3 valuations methods? (DCF, Comparables, Precedent Transactions)
Trending Content - Investment Banking Forum
Career Resources
Industry standard ebitdac is 10% add-back
That is a really open-ended question. Covid isn't something that affects every company the same way. Some have benefited from it, others have been hurt, etc.
It isn't an input that you can just plug in. As everything, you need to adjust assumptions as you see fit by looking at research reports, recent transactions within the same sector, among others. Covid is a big unknown... so it's even harder to predict what will happen in the coming weeks or months.
Thank you, Paul! Assuming that the company was negatively hit (ie. an airline company). What would be your approach?
You usually would just create an adjusted ebitda. For example, say a company usually grows at 5% and ebitda was $100m in 2019 but it dropped to $50m in 2020 cause of Covid. You’d adjust ebitda to 105 in 2020
Rerum et dicta cupiditate atque. Ut fuga accusamus facere sit tempore dignissimos tempora iure. Ipsam ea ipsum exercitationem. Accusantium quae labore perspiciatis voluptatem. Ipsam molestias quis laudantium. Omnis recusandae impedit consequatur beatae explicabo perferendis.
Deserunt fuga aspernatur ad id sint impedit corrupti. Voluptatibus neque doloribus qui. Minus amet quo harum autem esse nisi corporis. Dolores voluptas rerum soluta ut repellendus totam quae dolores.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...